Novotech Awarded the Asia Pacific CRO of the Year 2022 for Best Practices in Clinical Trials
December 05, 2022 14:44 ET
|
Novotech
SINGAPORE, Dec. 05, 2022 (GLOBE NEWSWIRE) -- Novotech, the leading Asia Pacific biotech specialist CRO, has been awarded the Frost & Sullivan Company of the Year Award 2022 for Best Practices in...
Clinical Research Opportunities in China and the Path to USFDA Approval – Whitepaper
October 30, 2022 18:10 ET
|
Novotech
SYDNEY, Australia, Oct. 30, 2022 (GLOBE NEWSWIRE) -- Novotech, the leading Asia Pacific biotech specialist CRO, and GlobalData have published the latest China biotech landscape analysis with expert...